- Home
- Publications
- Publication Search
- Publication Details
Title
A 40-Year Journey in Search of Selective Antiviral Chemotherapy*
Authors
Keywords
-
Journal
Annual Review of Pharmacology and Toxicology
Volume 51, Issue 1, Pages 1-24
Publisher
Annual Reviews
Online
2011-01-07
DOI
10.1146/annurev-pharmtox-010510-100228
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women
- (2010) Q. Abdool Karim et al. SCIENCE
- TMC278, a Next-Generation Nonnucleoside Reverse Transcriptase Inhibitor (NNRTI), Active against Wild-Type and NNRTI-Resistant HIV-1
- (2009) H. Azijn et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Alkoxyalkyl prodrugs of acyclic nucleoside phosphonates enhance oral antiviral activity and reduce toxicity: Current state of the art
- (2009) Karl Y. Hostetler ANTIVIRAL RESEARCH
- Early nucleoside reverse transcriptase inhibitors for the treatment of HIV: A brief history of stavudine (D4T) and its comparison with other dideoxynucleosides
- (2009) John C. Martin et al. ANTIVIRAL RESEARCH
- Nucleoside and nucleotide HIV reverse transcriptase inhibitors: 25 years after zidovudine
- (2009) Tomas Cihlar et al. ANTIVIRAL RESEARCH
- The AMD3100 story: The path to the discovery of a stem cell mobilizer (Mozobil)
- (2009) Erik De Clercq BIOCHEMICAL PHARMACOLOGY
- A new drug combination therapy for treatment-naive patients with HIV-1 infection, consisting of raltegravir, emtricitabine and tenofovir disoproxil fumarate
- (2009) Erik De Clercq EXPERT OPINION ON PHARMACOTHERAPY
- Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial
- (2009) Jeffrey L Lennox et al. LANCET
- Antiviral drug discovery: Ten more compounds, and ten more stories (part B)
- (2009) Erik De Clercq MEDICINAL RESEARCH REVIEWS
- Another ten stories in antiviral drug discovery (part C): “Old” and “new” antivirals, strategies, and perspectives
- (2009) Erik De Clercq MEDICINAL RESEARCH REVIEWS
- The next ten stories on antiviral drug discovery (part E): advents, advances, and adventures
- (2009) Erik De Clercq MEDICINAL RESEARCH REVIEWS
- A preemptive strike against HIV
- (2009) Cassandra Willyard NATURE MEDICINE
- The history of antiretrovirals: key discoveries over the past 25 years
- (2009) Erik De Clercq REVIEWS IN MEDICAL VIROLOGY
- Novel Nucleotide Human Immunodeficiency Virus Reverse Transcriptase Inhibitor GS-9148 with a Low Nephrotoxic Potential: Characterization of Renal Transport and Accumulation
- (2008) T. Cihlar et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Intracellular metabolism of the new antiviral compound 1-(S)-[3-hydroxy-2-(phosphonomethoxy)propyl]-5-azacytosine
- (2008) Lieve Naesens et al. BIOCHEMICAL PHARMACOLOGY
- GS-9219--A Novel Acyclic Nucleotide Analogue with Potent Antineoplastic Activity in Dogs with Spontaneous Non-Hodgkin's Lymphoma
- (2008) H. Reiser et al. CLINICAL CANCER RESEARCH
- Anti-HIV drugs: 25 compounds approved within 25 years after the discovery of HIV
- (2008) Erik De Clercq INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Tetrazolium-based colorimetric assay for the detection of HIV replication inhibitors: revisited 20 years later
- (2008) Christophe Pannecouque et al. Nature Protocols
- Tenofovir Disoproxil Fumarate versus Adefovir Dipivoxil for Chronic Hepatitis B
- (2008) Patrick Marcellin et al. NEW ENGLAND JOURNAL OF MEDICINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started